International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 2 , Pages 342-348 , 1 February 2010

The Rate of Secondary Malignancies After Radical Prostatectomy Versus External Beam Radiation Therapy for Localized Prostate Cancer: A Population-Based Study on 17,845 Patients

  • Naeem Bhojani, M.D.

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
    • Department of Urology, University of Montreal, Montreal, Canada
    • ,
  • Umberto Capitanio, M.D.

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
    • ,
  • Nazareno Suardi, M.D.

      Affiliations

    • Department of Urology, Vita-Salute San Raffaele, Milan, Italy
    • ,
  • Claudio Jeldres, M.D.

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
    • Department of Urology, University of Montreal, Montreal, Canada
    • ,
  • Hendrik Isbarn, M.D.

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
    • Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Shahrokh F. Shariat, M.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX
    • ,
  • Markus Graefen, M.D.

      Affiliations

    • Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Philippe Arjane, M.D.

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Canada
    • ,
  • Alain Duclos, M.D.

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Canada
    • ,
  • Jean-Baptiste Lattouf, M.D.

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Canada
    • ,
  • Fred Saad, M.D.

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Canada
    • ,
  • Luc Valiquette, M.D.

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Canada
    • ,
  • Francesco Montorsi, M.D.

      Affiliations

    • Department of Urology, Vita-Salute San Raffaele, Milan, Italy
    • ,
  • Paul Perrotte, M.D.

      Affiliations

    • Department of Urology, University of Montreal, Montreal, Canada
    • ,
  • Pierre I. Karakiewicz, M.D.

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
    • Department of Urology, University of Montreal, Montreal, Canada
    • Corresponding Author InformationReprint requests to: Pierre I. Karakiewicz, M.D., FRCSC., Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center (CHUM), 1058, rue St-Denis, Montréal, Québec, Canada, H2X 3J4. Tel: (514) 890-8000-35336; Fax: (514) 412-7363

Received 25 August 2008 ,Revised 6 February 2009 ,Accepted 7 February 2009.

References 

  1. Heidenreich A, Aus G, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol. 2008;53:68–80
  2. Barre C. Open radical retropubic prostatectomy. Eur Urol. 2007;52:71–80
  3. Berge V, Thompson T, Blackman D. Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting. Eur Urol. 2007;52:1036–1043
  4. Maffezzini M, Bossi A, Collette L. Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer. Eur Urol. 2007;51:605–613discussion 613
  5. Capitanio U, Scattoni V, Freschi M, et al. Radical prostatectomy for incidental (Stage t1a-t1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur Urol. 2008;54:118–125
  6. Litwin MS, McGuigan KA, Shpall AI, et al. Recovery of health related quality of life in the year after radical prostatectomy: Early experience. J Urol. 1999;161:515–519
  7. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129–135
  8. Karakiewicz PI, Bhojani N, Neugut A, et al. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. J Sex Med. 2008;5:919–927
  9. Hanlon AL, Watkins Bruner D, Peter R, et al. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: Comparing late bowel and bladder quality of life symptoms to that of the normal population. Int J Radiat Oncol Biol Phys. 2001;49:51–59
  10. Lilleby W, Fossa SD, Waehre HR, et al. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys. 1999;43:735–743
  11. Leborgne F, Fowler J. Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: Nonrandomized contemporary comparison with standard fractionation. Int J Radiat Oncol Biol Phys. 2008;72:770–776
  12. Fonteyne V, Villeirs G, Speleers B, et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys. 2008;72:799–807
  13. Faria SL, Souhami L, Joshua B, et al. Reporting late rectal toxicity in prostate cancer patients treated with curative radiation treatment. Int J Radiat Oncol Biol Phys. 2008;72:777–781
  14. Ferrer M, Suarez JF, Guedea F, et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:421–432
  15. Mols F, Korfage IJ, Vingerhoets AJ, et al. Bowel, urinary, and sexual problems among long-term prostate cancer survivors: A population-based study. Int J Radiat Oncol Biol Phys. 2009;73:30–38
  16. Kry SF, Followill D, White RA, et al. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:1265–1271
  17. Damber JE, Aus G. Prostate cancer. Lancet. 2008;371:1710–1721
  18. Bostrom PJ, Soloway MS. Secondary cancer after radiotherapy for prostate cancer: Should we be more aware of the risk?. Eur Urol. 2007;52:973–982
  19. Moon K, Stukenborg GJ, Keim J, et al. Cancer incidence after localized therapy for prostate cancer. Cancer. 2006;107:991–998
  20. Brenner DJ, Curtis RE, Hall EJ, et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer. 2000;88:398–406
  21. Liauw SL, Sylvester JE, Morris CG, et al. Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys. 2006;66:669–673
  22. Boorjian S, Cowan JE, Konety BR, et al. Bladder cancer incidence and risk factors in men with prostate cancer: Results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2007;177:883–887discussion 887–888
  23. Neugut AI, Ahsan H, Robinson E, et al. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer. 1997;79:1600–1604
  24. Kry SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62:1195–1203
  25. Jeldres C, Suardi N, Capitanio U, et al. High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer. BJU Int. 2008;102:463–467
  26. Jeldres C, Suardi N, Saad F, et al. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol. 2008;54:97–105
  27. Jeldres C, Suardi N, Walz J, et al. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: A population-based study of 6183 men. Eur Urol. 2008;54:107–116
  28. Walz J, Gallina A, Perrotte P, et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int. 2007;100:1254–1258
  29. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49:1429–1433
  30. Baxter NN, Tepper JE, Durham SB, et al. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology. 2005;128:819–824
  31. Pickles T, Phillips N. The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. Radiother Oncol. 2002;65:145–151
  32. Karakiewicz PI, Bazinet M, Aprikian AG, et al. Thirty-day mortality rates and cumulative survival after radical retropubic prostatectomy. Urology. 1998;52:1041–1046
  33. Walz J, Montorsi F, Jeldres C, et al. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: A population-based analysis of 9208 consecutive cases. BJU Int. 2008;101:826–832

 Drs. Bhojani and Capitano contributed equally to this work.

 Dr. Pierre I. Karakiewicz is partially supported by the University of Montreal Urology Associates, Fonds de la Recherche en Santé du Québec, the University of Montreal, Department of Surgery and the University of Montreal Foundation.

 Conflict of interest: none.

PII: S0360-3016(09)00251-X

doi: 10.1016/j.ijrobp.2009.02.011

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 2 , Pages 342-348 , 1 February 2010

Article Tools

* Image Usage & Resolution